Contact Information
Email
s****@sparingvision.com
Unlock
Company Information
Total Funding
148983220.0
Technologies
Outlook
Microsoft Office 365
reCAPTCHA
Vimeo
Mobile Friendly
Nginx
Google Maps
Apache
WordPress.org
Google Font API
Remote
AI
Keywords
ocular diseases
inherited retinal diseases
irds
gene therapy
genomic medicines
retinitis pigmentosa
rp
therapeutic innovation
gene agnostic
mutations
photoreceptors
cone viability factor
anti-oxidative stress
subretinal injection
clinical-stage
clinical trial
mutation independent
neuroprotective therapy
aav-based delivery
crispr/cas9
genome editing
ocular drug discovery
vision saving treatments
progressive vision loss
optical restoration
blindness prevention
patient outcomes
dormant cones
visual acuity restoration
genetic mutation
phototransduction cascade
gene therapy approaches
gene replacement
genetic disorders
advanced stage treatment
biopharmaceutical pipeline
treatment development
safety data trials
preliminary efficacy
patient care
optogenetics
biological research
genetic intervention
therapeutic synergy
long-term results
active clinical research
medical advancements
therapy options
retinal degeneration therapies
combined therapy constructs
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans